|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.020 EUR | -0.50% |
|
+1.49% | +10.27% |
| 05-05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 192M 219M 177M 164M 311M 20.94B 316M 2.12B 831M 10.28B 824M 806M 35.62B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 192M 219M 177M 164M 311M 20.94B 316M 2.12B 831M 10.28B 824M 806M 35.62B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.24x |
| Free-Float |
12.27% | Yield 2026 * |
0.99% | Yield 2027 * | 0.99% |
| 1 day | -0.50% | ||
| 1 week | +1.49% | ||
| Current month | +3.03% | ||
| 1 month | +2.51% | ||
| 3 months | +15.25% | ||
| 6 months | +9.09% | ||
| Current year | +10.27% |
| 1 week | 3.92 |  | 4.1 |
| 1 month | 3.9 | | 4.18 |
| Current year | 3.22 | | 4.26 |
| 1 year | 2.86 | | 4.26 |
| 3 years | 2.28 | | 4.26 |
| 5 years | 2.28 | | 4.26 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 31/12/2002 |
Michael Bock
BRD | Director/Board Member | 63 | 24/05/2005 |
| Director/Board Member | 63 | 19/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.50% | +1.49% | +38.78% | +36.00% | 219M | |
| +1.44% | +3.30% | +26.54% | +45.77% | 18.03B | |
| -0.05% | -0.59% | +20.14% | +71.39% | 13.32B | |
| -0.12% | -3.31% | -33.55% | -54.07% | 11.19B | |
| -1.65% | +2.14% | -6.99% | +64.20% | 11.01B | |
| -0.88% | -0.12% | +14.34% | +86.60% | 9.79B | |
| +1.56% | -1.02% | -2.50% | -27.10% | 9.28B | |
| +1.74% | -0.68% | +25.15% | +200.02% | 7.53B | |
| -2.31% | -5.00% | +10.63% | -24.02% | 6.85B | |
| +0.88% | +2.24% | -22.71% | - | 6.84B | |
| Average | +0.01% | +0.02% | +6.98% | +44.31% | 9.41B | |
| Weighted average by Cap. | +0.16% | +0.06% | +5.60% | +43.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 900M 726M 672M 1.28B 85.92B 1.3B 8.7B 3.41B 42.19B 3.38B 3.31B 146B | 803M 918M 741M 685M 1.3B 87.64B 1.32B 8.87B 3.48B 43.04B 3.45B 3.37B 149B |
| Net income | 36.66M 41.91M 33.81M 31.28M 59.37M 4B 60.37M 405M 159M 1.96B 157M 154M 6.8B | 38.2M 43.66M 35.22M 32.59M 61.86M 4.17B 62.89M 422M 165M 2.05B 164M 160M 7.09B |
| Net Debt | - | - |
Employees
7,416
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | €4.080 | +0.99% | 24 |
| 09/07/26 | €4.040 | 0.00% | 4,492 |
| 08/07/26 | €4.040 | +0.50% | 2,402 |
| 07/07/26 | €4.020 | -0.99% | 2,170 |
| 06/07/26 | €4.060 | +1.00% | 2,841 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.040EUR
Average target price
7.300EUR
Spread / Average Target
+80.69%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
